A drug used now to treat Type 2 diabetes may someday help beat breast and ovarian cancers, but not until researchers decode the complex interactions that in some cases help promote tumors, according to Rice University scientists.
Biochemistry
Nov 30, 2016
0
220
Ovarian cancer kills 14,000 women in the United States every year. It's the fifth leading cause of cancer death among women, and it's so deadly, in part, because the disease is hard to catch in its early stages. Patients ...
Bio & Medicine
May 16, 2022
0
53
Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated ...
Bio & Medicine
Sep 13, 2022
0
155
A team of Yale University scientists has synthesized for the first time a chemical compound called lomaiviticin aglycon, leading to the development of a new class of molecules that appear to target and destroy cancer stem ...
Biochemistry
Jan 31, 2011
0
0
Damage to DNA is a daily occurrence but one that human cells have evolved to manage. Now, in a new paper published in Nature Structural & Molecular Biology, Mayo researchers have determined how one DNA repair protein gets ...
Cell & Microbiology
Jul 2, 2018
0
39
Considered the most lethal form of DNA damage, double-strand breaks must be repaired to prevent cell death. In developing therapies for hard-to-treat breast and ovarian cancers in patients with BRCA gene mutations, scientists ...
Cell & Microbiology
Feb 11, 2021
0
271
A common chemotherapy drug has been successfully delivered to cancer cells inside tiny microparticles using a method inspired by our knowledge of how the human immune system works. The drug, delivered in this way, reduced ...
Biotechnology
Sep 12, 2011
0
0
Maybe you go for a leisurely walk, curl up with a good book, lift weights or reach for some comfort food when you're not feeling well or have had a particularly stressful day. Although there are myriad ways that we all outwardly ...
Plants & Animals
Nov 18, 2020
0
40
(AP) -- Patricia Dunn, the former Hewlett-Packard Co. chairwoman who authorized a boardroom surveillance probe that ultimately sullied her remarkable rise from investment bank typist to the corporate upper class, has died ...
Business
Dec 6, 2011
1
0
A team of sciences from the RUDN Institute of Medicine has reported how reactive oxygen species (ROSs) affect the resistance of ovarian cancer cells to chemotherapy on the example of cisplatin—an antitumor drug used to ...
Biochemistry
Sep 13, 2018
0
12
